| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/07/2010 | EP2203480A1 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf) |
| 07/07/2010 | EP2203479A2 Inhibition of angiogenesis |
| 07/07/2010 | EP2203182A1 Synthetic antigenic peptides and lipopeptides derived fro mycobacterium avium subsp. paratuberculosis |
| 07/07/2010 | EP1802337B1 Consortium of nitrifying bacteria |
| 07/07/2010 | EP1682178B1 Methods of therapy for cancers expressing the cd40 antigen |
| 07/07/2010 | EP1620550B1 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| 07/07/2010 | EP1618128B1 Tuberculosis vaccine with improved efficacy |
| 07/07/2010 | EP1597367B1 Glycoprotein antigen sima135 expressed in metastatic human tumor cells |
| 07/07/2010 | EP1545595B1 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 07/07/2010 | EP1470218B1 Corona-virus-like particles comprising functionally deleted genomes |
| 07/07/2010 | EP1446158B1 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including cd4 |
| 07/07/2010 | EP1418941B1 Inducted immune response against the feline immunodeficiency virus |
| 07/07/2010 | EP1383919B1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 07/07/2010 | EP1334201B1 Dna expression vectors |
| 07/07/2010 | EP1260581B1 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell |
| 07/07/2010 | EP1079862B1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 07/07/2010 | EP0979284B2 Reagents for vaccination which generate a cd8 t cell immune response |
| 07/07/2010 | CN1778816B Human cell surface membrane molecule and use thereof |
| 07/07/2010 | CN101772580A Methods for production and uses of multipotent cell populations |
| 07/07/2010 | CN101772576A Baculoviral vectors with a dual vertebrate and baculovirus promoter controlling an immunogenic fusion gene |
| 07/07/2010 | CN101768575A Construction of recombinant rabies virus of double-expression G gene and biological property analysis thereof |
| 07/07/2010 | CN101768565A Bacillus anthracis capable of displaying PAD4 protein on surface of spore and application thereof |
| 07/07/2010 | CN101766815A Application of taxol and taxotere |
| 07/07/2010 | CN101766814A Swine pasteurellosis bivalent inactivated vaccine and preparation method thereof |
| 07/06/2010 | US7750138 consisting of different fragments of the VEGF receptors FLT-1 and KDR and human immunoglobulin Fc; treatment of angiogenesis-related diseases including tumor, diabetic retinopathies, arthritis, anemia and endometrial hyperplasia; vectors; host cell |
| 07/06/2010 | US7750136 Using ribosome-inactivating protein (RIP)/cytotoxin fusion to target and destroy tumor cells |
| 07/06/2010 | US7750133 Vascular endothelial cell growth inhibitor, VEGI-192a |
| 07/06/2010 | US7750125 C35 tumor antigen specific monoclonal for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/06/2010 | US7750124 Delta-like 4 receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/06/2010 | US7750123 Immunoglobulin for treatment and prevention of severe acute respiratory syndrome and/or coronavirus related disorders |
| 07/06/2010 | US7750122 Anti-TrkB monoclonal antibodies and uses thereof |
| 07/06/2010 | US7750121 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 07/06/2010 | US7750117 Mixing protein with a saccharide compound in a liquid suspension and then drying to produce a solid that contains the protein and the saccharide |
| 07/06/2010 | US7749979 CpG DNA adjuvant in avian vaccines |
| 07/06/2010 | US7749975 immunomers comprising at least two oligonucleotides linked at their 3' ends by internucleoside linkages, functionalized nucleobase or sugar to a non-nucleotidic linkers, used for treating cancer, autoimmune diseases, airway inflammation, inflammatory or skin disorders, allergy or asthma |
| 07/06/2010 | US7749962 administering to mammal with breast cancer as adjuvant therapy an agent effective in blocking interaction of integrin with extracellular matrix protein of bone marrow microenvironment or that downregulates expression of integrin; integrin is alpha 5 beta 1 and extracellular matrix protein is fibronectin |
| 07/06/2010 | US7749752 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 07/06/2010 | US7749746 Nucleic acid encoding 238P1B2 useful in detecting cancer |
| 07/06/2010 | US7749745 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine |
| 07/06/2010 | US7749744 Hybrid enzymes |
| 07/06/2010 | US7749734 Attenuated chimeric flavivirus bearing attenuated Japanese encephalitis virus gene as backbone |
| 07/06/2010 | US7749719 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy |
| 07/06/2010 | US7749718 Method for raising or isolating an antibody to DCRS5 |
| 07/06/2010 | US7749519 Unique DNA and polypeptide sequences based on the circumsporozoite protein of Plasmodium vivax |
| 07/06/2010 | US7749518 Viral protein for use in devloping vaccine for treatment and preventon of infection, vision, arthritic and respiratory system disorders |
| 07/06/2010 | US7749517 administering to a human or non-human animal infected by or exposed to anthrax a polypeptide that inhibits binding between protective antigen (PA) and human capillary morphogenesis protein-2 (CMG-2) at a level effective to reduce the severity of anthrax infection |
| 07/06/2010 | US7749516 Immunization of dairy cattle with GapC protein against Streptococcus infection |
| 07/06/2010 | US7749515 Therapy or prevention of headaches; administering neurotoxin by injection |
| 07/06/2010 | US7749514 Activatable clostridial toxins |
| 07/06/2010 | US7749513 lowering plasma cholesterol level in a subject by administering a preparation comprising an isolated membrane fraction separated from cytoplasmic material, the membrane fraction made from bacteria of Rhodospirillum spp. and/or Phaeospirillum spp |
| 07/06/2010 | US7749512 Helicobacter cordo (H.C.) is a new pathogen isolated from swine withgastritis/ulcer disease; preventing an H.C.infection by eliciting an immune response against H.C. by administering a vaccine basedon a Helicobacter porcine gastric isolate lysate producedby proteolytic digestion of H. pylori bacteria |
| 07/06/2010 | US7749511 An immunogenic conjugate comprising a plurality of deacylated lipopolysaccharide molecules from a gram-negative bacterium covalently linked to gucosamine residue of D.discodideum proteinase 1 |
| 07/06/2010 | US7749510 Episome for transfer and expression of heterologous nucleotide sequences in gram positive bacteria; genetic vaccines |
| 07/06/2010 | US7749509 Administering a probiotic composition comprising Bacillus subtilis, Bacillus coagulans and Enterococcus faecium,in a non-microencapsulated form; including a carrier such as fructooligosaccharides; dosage; physiological disorders; fungicides; nutrients; food additives; drugs |
| 07/06/2010 | US7749507 Malaria vaccine |
| 07/06/2010 | US7749506 Envelope protein for use as immunization tool in treatment and prevention of viral disease in crustaceans |
| 07/06/2010 | US7749505 Immunogenic polypeptides for use in targeted treatment and prevention of cell proliferative disorders associated with respiratory system |
| 07/06/2010 | US7749504 Anti-TAT188 antibodies |
| 07/06/2010 | US7749502 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis |
| 07/06/2010 | US7749501 Engineered antibody-stress protein fusions |
| 07/06/2010 | US7749500 Antibodies to IL-17 polypeptides and therapeutic uses thereof |
| 07/06/2010 | US7749499 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |
| 07/06/2010 | US7749498 Binding native human tissue factor (TF) and does not substantially bind non-native tissue factor; superior anticoagulant activity by binding with high affinity and specificity; reducing cancer cell tissue factor activity and detecting cancer cells that express TF; factor X binding is inhibited |
| 07/06/2010 | US7749496 Neuronal regeneration |
| 07/06/2010 | CA2370814C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 07/06/2010 | CA2328056C Attenuated mutants of salmonella which constitutively express the vi antigen |
| 07/06/2010 | CA2264509C Novel monoclonal antibody recognizing cell surface antigen cd14 |
| 07/06/2010 | CA2209360C Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 07/06/2010 | CA2162729C Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s) |
| 07/06/2010 | CA2150785C Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| 07/01/2010 | WO2010075525A1 Method of using tumor cell debris to reduce brain tumor recurrence or growth |
| 07/01/2010 | WO2010075491A2 Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins |
| 07/01/2010 | WO2010075423A2 Dendrimer based modular platforms |
| 07/01/2010 | WO2010075249A2 A method for treating rheumatoid arthritis with b-cell antagonists |
| 07/01/2010 | WO2010074991A1 Ex-vivo passive protection bacteremia assay |
| 07/01/2010 | WO2010074724A1 Combination of aurora kinase inhibitors and anti-cd20 antibodies |
| 07/01/2010 | WO2010074656A1 Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza a viruses and uses thereof |
| 07/01/2010 | WO2010074575A2 Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv. |
| 07/01/2010 | WO2010074541A2 Drug delivery carrier using zz domain |
| 07/01/2010 | WO2010074540A2 Pharmaceutical composition containing an anionic drug, and a production method therefor |
| 07/01/2010 | WO2010074266A1 Anti-cd4 antibody |
| 07/01/2010 | WO2010074218A1 Anti-human midkine antibody |
| 07/01/2010 | WO2010074192A1 Diagnosis and treatment of cancer using anti-lgr7 antibody |
| 07/01/2010 | WO2010074126A1 Recombinant avian-infectious coryza vaccine and method for producing same |
| 07/01/2010 | WO2010074049A1 Anti-hs6st2 antibody and use thereof |
| 07/01/2010 | WO2010073694A1 Diagnosis of treatment of cancer using anti-tm4sf20 antibody |
| 07/01/2010 | WO2010073647A1 Human anti-human influenza virus antibody |
| 07/01/2010 | WO2010073551A1 C1orf59 peptides and vaccines including the same |
| 07/01/2010 | WO2010073204A1 Anti-hcv monoclonal antibody as a medicament for the therapeutic treatment and prevention of hcv infections |
| 07/01/2010 | WO2010073119A1 Stable pharmaceutical composition containing at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents |
| 07/01/2010 | WO2010073104A2 Improving cognitive function |
| 07/01/2010 | WO2010073043A1 Immunogenic composition and use thereof |
| 07/01/2010 | WO2010073019A1 Ljungan virus |
| 07/01/2010 | WO2010072743A1 Immunostimulating saponins for use in in situ tumor-destruction therapy |
| 07/01/2010 | WO2010072741A1 TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREFOR |
| 07/01/2010 | WO2010072740A2 TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREOF |
| 07/01/2010 | WO2010072691A1 Antibodies against tissue factor pathway inhibitor |
| 07/01/2010 | WO2010072381A1 Immunoglobulin purification |
| 07/01/2010 | WO2010072365A1 Single recombination system and methods of use |
| 07/01/2010 | WO2010071986A1 Modified steptococcus pneumonia pneumolysin (ply) polypeptides |